Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
- 5 April 1998
- journal article
- review article
- Published by Wiley in Brain Pathology
- Vol. 8 (2), 299-324
- https://doi.org/10.1111/j.1750-3639.1998.tb00156.x
Abstract
Lewy body formation is central to the pathological phenotype of a spectrum of disorders. The most familiar of these is the extrapyramidal syndrome of idiopathic Lewy‐body Parkinson's disease (PD). Studies of dementia in the elderly suggest that another manifestation of Lewy body pathology is equally or more common than Parkinson's disease. This syndrome of Dementia with Lewy bodies (DLB) has been given a number of diagnostic labels and is characterised by dementia, relatively mild parkinsonism, visual hallucinations, and fluctuations in conscious level. Although many of these features can arise in Parkinson's disease, the patients with DLB tend to have early neuropsychiatric features which predominate the clinical picture, and the diagnosis of the syndrome in practice is more concerned with the differential diagnosis of Alzheimer's disease (AD). Distinction from AD has clinical importance because of potentially differing therapeutic implications. Diagnostic guidelines for the clinical diagnosis and pathological evaluation of DLB are reviewed. Research into the disorder has centered around characterising the clinical, neuropsychological, pathological, neurochemical and genetic relationships with Alzheimer's disease on the one hand, and Parkinson's disease on the other. Many cases of DLB have prominent pathological features of AD and there are some shared genetic risk factors. Differences from the pathology of PD are predominantly quantitative rather than qualitative and evidence is discussed which suggests that DLB represents a clinicopathological syndrome within the spectrum of Lewy body disorders. The possibility that the syndrome represents a chance association of PD and AD is not supported by published studies.Keywords
This publication has 106 references indexed in Scilit:
- Clinical neurochemistry: developments in dementia research based on brain bank materialJournal of Neural Transmission, 1998
- Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13?Annals of Neurology, 1997
- No Association between Parkinson's Disease and Low-Activity Alleles of CatecholO-MethyltransferaseBiochemical and Biophysical Research Communications, 1996
- Mutation frequencies of the cytochromeCYP2D6 gene in Parkinson disease patients and in familiesAmerican Journal of Medical Genetics, 1996
- Apolipoprotein E genotypes in Parkinson's disease with and without dementiaAnnals of Neurology, 1995
- The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's diseaseAnnals of Neurology, 1995
- Hereditary variations in monoamine oxidase as a risk factor for Parkinson's diseaseMovement Disorders, 1994
- Alzheimer's disease and Lewy body disease: A comparative clinicopathological studyAnnals of Neurology, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Epitopes located in spatially separate domains of each neurofilament subunit are present in parkinson's disease lewy bodiesJournal of Comparative Neurology, 1991